// App-Quantinova.ai

1076 : Outcome of (Novel) Subgroups in 1257 Pediatric Patients with KMT2A-Rearranged Acute Myeloid Leukemia (AML) and the Significance of Minimal Residual Disease (MRD) Status: A Retrospective Study By the I-BFM-SG

Researchers

Presenter

  • Romy E. Van Weelderen

Principal Investigators

  • Bianca F. Goemans

  • Christian M. Zwaan

  • Hester A. De Groot-Kruseman

  • Jonas Abrahamsson

  • Nira Arad-Cohen

  • Emmanuelle Bart-Delabesse

  • Barbara Buldini

  • Barbara De Moerloose

  • Michael Dworzak

  • Sarah Elitzur

  • Jos M. Fernndez Navarro

  • Robert B. Gerbing

  • Erin Guest

  • Shau-Yin Ha

  • Christine J. Harrison

  • Henrik Hasle

  • Kathy Jackson

  • Charikleia Kelaidi

  • Hlne Lapillonne

  • Guy Leverger

  • Franco Locatelli

  • Takako Miyamura

  • Sophia Polychronopoulou

  • Mareike Rasche

  • Jeffrey E. Rubnitz

  • Jan Stary

  • Daisuke Tomizawa

  • Femke Verwer

  • Gertjan J.L. Kaspers

Medical Centers

  • Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

  • Department of Pediatric Oncology, Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands

  • Department of Pediatric Endocrinology, Emma Children’s Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

  • Wilhelmina Childrens Hospital, University Medical Center, Utrecht, Netherlands

  • Princess Maxima Center for Pediatric Oncology, Netherlands

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Dutch Childhood Oncology Group (SKION),Utrecht,Netherlands

  • Department of Pediatrics, Queen Sylvias Children Hospital, Gothenburg, Sweden

  • Pediatric Hematology Oncology Department, Ruth Rappaport Children’s Hospital, Rambam Health Care Campus, Haifa, Israel

  • Laboratoire d'Hématologie secteur Génétique des Hémopathies, IUC Toulouse-Oncopole, Toulouse, France

  • Clinic of Pediatric Hemato-Oncology, Department of Womens and Childrens Health, University of Padua, Padua, Italy

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium

  • St. Anna Children's Hospital and Cancer Research Institute,Pediatric Clinic, Medical University of Vienna,Vienna,Austria

  • Pediatric Hematology and Oncology, Schneider Children's Medical Center and Tel Aviv University, Tel Aviv, Israel

  • Pediatric Oncology, Hospital Universitari i Politecnic La Fe, Valencia, Spain

  • Children's Oncology Group, Monrovia, CA

  • Division of Hematology/Oncology/Bone Marrow Transplantation, Childrens Mercy Hospitals and Clinics, Kansas City, MO

  • Department of Medicine, Queen Mary Hospital, Hong Kong, Hong Kong

  • Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, ENG, United Kingdom

  • Aarhus University Hospital, Aarhus, Denmark

  • St. Jude Children's Research Hospital, Memphis, TN

  • Department of Pediatric Haematology-Oncology, Aghia Sophia Childrens Hospital, Athens, Greece

  • Pediatric Hematology and Oncology Department, Hôpital Armand Trousseau, Paris, France

  • Pediatric Hematology and Oncology Department, Hôpital Armand Trousseau, Paris, France

  • Department of Pediatric Hematology and Oncology , IRCCS Ospedale Bambino Gesu, Rome , Italy

  • Department of Radiology, Okayama University Graduate School of Medicine, Okayama, Japan

  • Department of Pediatric Hematology and Oncology, University Giessen, Giessen, Germany

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

  • Department of Paediatric Haematology and Oncology, Charles University 2nd Medical School, Prague, Czech Republic

  • Childrens Cancer Center, National Center of Child Health and Development, Tokyo, Japan

Locations

  • Netherlands

  • Sweden

  • Israel

  • France

  • Italy

  • Belgium

  • Austria

  • Spain

  • United States

  • Hong Kong

  • United Kingdom

  • Denmark

  • Greece

  • Japan

  • Germany

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved